Additional index words. Solanum lycopersicum, greenhouse, season extension, plasticulture, hoop house, local markets, IPM Abstract. Organic and heirloom tomatoes are high-value products with growing demand but there are many challenges to successful cultivation. A systems comparison study was carried out to evaluate the production of the popular heirloom tomato 'Cherokee Purple' (Solanum lycopersicum L.) under high tunnel and open field systems in North Carolina from 2007 to 2008. Management of the high tunnel (i.e., temperature and irrigation), weather events as well as pest and disease pressure influenced crop quality and yield. The high tunnel and field systems achieved similar total yields (100 t · ha L1 ) the first season but yields were 33% greater in the high tunnel system than the field system in the second year (100 t · ha L1 and 67 t · ha L1 , respectively). Both years, the tomatoes were planted in high tunnels 1 month earlier and harvested 3 weeks earlier than the field. The accumulation of ' '1100 growing degree-days (GDD) was required in both systems before 50% of the fruit was harvested. Fruit cracking, cat-facing, blossom-end rot, and insect damage were the major categories of defects in both systems. Incidence of both Tomato Spotted Wilt Virus (TSWV) and Gray Leaf Spot (GLS) were lower in the high tunnel compared with the field in 2007 and 2008, respectively. Results of this study suggest that with proper management techniques, high tunnels can optimize yields, increase fruit quality, and provide season extension opportunities for high-value horticultural crops.
Background Lipid nanoparticle (LNP) encapsulated self-amplifying RNA (saRNA) is a novel technology formulated as a low dose vaccine against COVID-19.Methods A phase I first-in-human dose-ranging trial of a saRNA COVID-19 vaccine candidate LNP-nCoVsaRNA, was conducted at Imperial Clinical Research Facility, and participating centres in London, UK, between 19 th June to 28 th October 2020. Participants received two intramuscular (IM) injections of LNP-nCoVsaRNA at six different dose levels, 0.1-10.0mg, given four weeks apart. An open-label dose escalation was followed by a dose evaluation. Solicited adverse events (AEs) were collected for one week from enrolment, with follow-up at regular intervals (1-8 weeks). The binding and neutralisation capacity of anti-SARS-CoV-2 antibody raised in participant sera was measured by means of an anti-Spike (S) IgG ELISA, immunoblot, SARS-CoV-2 pseudoneutralisation and wild type neutralisation assays. (The trial is registered: ISRCTN17072692, EudraCT 2020-001646-20).Findings 192 healthy individuals with no history or serological evidence of COVID-19, aged 18-45 years were enrolled. The vaccine was well tolerated with no serious adverse events related to vaccination. Seroconversion at week six whether measured by ELISA or immunoblot was related to dose (both p<0.001), ranging from 8% (3/39; 0.1mg) to 61% (14/23; 10.0mg) in ELISA and 46% (18/39; 0.3mg) to 87% (20/23; 5.0mg and 10.0mg) in a post-hoc immunoblot assay. Geometric mean (GM) anti-S IgG concentrations ranged from 74 (95% CI, 45-119) at 0.1mg to 1023 (468-2236) ng/mL at 5.0mg (p<0.001) and was not higher at 10.0mg. Neutralisation of SARS-CoV-2 by participant sera was measurable in 15% (6/39; 0.1mg) to 48% (11/23; 5.0mg) depending on dose level received.Interpretation Encapsulated saRNA is safe for clinical development, is immunogenic at low dose levels but failed to induce 100% seroconversion. Modifications to optimise humoral responses are required to realise its potential as an effective vaccine against SARS-CoV-2.
Both regulatory and consumer forces have increased the demand for biopesticides, particularly in amenity areas such as turfgrass. Unfortunately, few natural products are available for selective weed control in turfgrass. Two bioherbicides reported to control broadleaf weeds without injuring turfgrass arePhoma macrostomaand thaxtomin A. Field and container experiments were conducted to evaluate PRE and POST efficacy ofP. macrostomaand thaxtomin A on regionally important broadleaf weeds. In container experiments, PRE applications ofP. macrostomaprovided 65 to 100% control of dandelion, marsh yellowcress, and flexuous bittercress, equivalent to that of pendimethalin. Control of yellow woodsorrel, henbit, hairy galinsoga, common chickweed, or annual bluegrass was less than with pendimethalin. In contrast, POST applications did not control any species as well as an industry-standard synthetic auxin herbicide. PRE or POST applications of thaxtomin A controlled six of the eight species tested as well as the industry-standard PRE or POST herbicides. In field tests, overall PRE broadleaf weed control withP. macrostomaand thaxtomin A peaked 4 wk after treatment at 64 and 72%, respectively, and declined afterward, suggesting that these bioherbicides possess short residuals and therefore must be reapplied for season-long control. Overall POST broadleaf weed control usingP. macrostomaand thaxtomin A was only 41 and 25%, respectively. PRE followed by early-POST applications of thaxtomin A provided ≥ 86% henbit control. These results suggest that bothP. macrostomaand thaxtomin A are capable of controlling certain broadleaf weeds in turfgrass. However, both lack efficacy on some important weed species, particularly chickweed. Thaxtomin A efficacy on henbit was improved by increased dose and by PRE followed by early-POST applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.